Ro launches tool to check insurance coverage for GLP-1 drugs, aiming to help patients

From CNBC: 2024-08-13 10:00:29

Ro, a health-care startup, launched a free tool to help patients determine insurance coverage for GLP-1 weight loss and diabetes drugs. Most plans cover these drugs for diabetes treatment, but not weight loss. Ro’s tool aims to help patients understand coverage options and make informed decisions about pursuing weight loss treatments. Demand for GLP-1s has outstripped supply in the U.S., with the market potentially reaching over $100 billion by the end of the decade. Ro’s program offers GLP-1 prescriptions, educational resources, coaching, and insurance navigation to support patients through their weight management journey. The insurance tool provided by Ro requires patients to input medical and insurance information, receiving a personalized report in one to three days outlining coverage, prior authorization requirements, estimated copays, and next steps. Sample reports show insurance coverage details, supply availability, estimated copays, and potential out-of-pocket costs for drugs like Wegovy and Ozempic. Ro’s tool aims to provide valuable information early in the patient journey to influence downstream decision-making.



Read more at CNBC: Ro launches GLP-1 insurance coverage checker